Combivent respimat and Singulair drug interactions - from FDA reports


Drug interactions are reported among people who take Combivent respimat and Singulair together. This study is created by eHealthMe based on reports of 41 people who take Combivent respimat and Singulair from FDA, and is updated regularly.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our independent and original studies have been referenced on 400+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO.



On Aug, 10, 2018

41 people who take Combivent respimat, Singulair are studied.


Number of reports submitted per year:

Combivent respimat and Singulair drug interactions.

Most common drug interactions over time *:

1 - 2 years:
  1. Depression
  2. Fluid retention (an abnormal accumulation of fluid in the blood)
  3. Therapeutic response unexpected
Personalize this study to your gender and age

Most common drug interactions by gender *:

Subscribe to monitor Combivent respimat and Singulair

Most common drug interactions by age *:

30-39:
  1. Abdominal pain
  2. Anaemia (lack of blood)
  3. Benign ovarian tumour
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  5. Dyspepsia (indigestion)
40-49:
  1. Abnormal loss of weight
  2. Anxiety
  3. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  4. Gastric disorder (disease of stomach)
  5. Pain
50-59:
  1. Hyperhidrosis (abnormally increased sweating)
  2. Irritability
  3. Panic attack
  4. Visual impairment
  5. Aneurysm (enlargement of an artery caused by a weakening of the artery wall)
Click here to get more results

* Approximation only. Some reports may have incomplete information.

Are you new to Combivent respimat and Singulair or have questions?

Volunteer or get paid to help people with your care experience



Related studies

Combivent respimat

Combivent respimat has active ingredients of albuterol sulfate; ipratropium bromide. It is often used in chronic obstructive pulmonary disease. (latest outcomes from Combivent respimat 588 users)

Singulair

Singulair has active ingredients of montelukast sodium. It is often used in asthma. (latest outcomes from Singulair 69,937 users)


Interactions between Combivent respimat and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Interactions between Singulair and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Browse all drug interactions of Combivent respimat and Singulair
a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

What would happen?

Predict new side effects and undetected conditions when you take Combivent respimat and Singulair

You are not alone. Join our personalized support groups:

You may be interested in these posts

More posts for: Combivent respimat, Singulair

Recent updates

General studies
Active Support Groups
Recent Care Guides

You could also:

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.